Parham Ramezani-Rad

1 month ago | jci.org | Parham Ramezani-Rad |Ester Marina-Zárate |Laura Maiorino |Amber Myers

ResearchAIDS/HIVImmunologyOpen Access | 10.1172/JCI185292 J Clin Invest. https://doi.org/10.1172/JCI185292. Copyright © 2025, Ramezani-Rad et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Aug 3, 2024 | biorxiv.org | Parham Ramezani-Rad |Ester Marina-Zárate |Laura Maiorino |Amber Myers

AbstractThe induction of durable protective immune responses is the main goal of prophylactic vaccines, and adjuvants play an important role as drivers of such responses. Despite advances in vaccine strategies, a safe and effective HIV vaccine remains a significant challenge. The use of an appropriate adjuvant is crucial to the success of HIV vaccines.